MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer
about
The Role of microRNAs in the Diagnosis and Treatment of Pancreatic AdenocarcinomaThe Role of miRNAs in the Regulation of Pancreatic Cancer Stem CellsEmerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review)The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus.Expression and clinical significance of microRNA-1246 in human oral squamous cell carcinomaCyclin G2: A novel independent prognostic marker in pancreatic cancer.Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma.Comprehensive phenotypic analysis of knockout mice deficient in cyclin G1 and cyclin G2.MicroRNA profiling of low-grade glial and glioneuronal tumors shows an independent role for cluster 14q32.31 member miR-487bMicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma.MicroRNA-181b-5p, ETS1, and the c-Met pathway exacerbate the prognosis of pancreatic ductal adenocarcinoma after radiation therapy.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.The Role of MicroRNAs in Resistance to Current Pancreatic Cancer Treatment: Translational Studies and Basic Protocols for Extraction and PCR Analysis.Evidence for the role of microRNA 374b in acquired cisplatin resistance in pancreatic cancer cells.microRNA regulation of human pancreatic cancer stem cells.PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells.Prognostic Impact of Peritumoral IL-17-Positive Cells and IL-17 Axis in Patients with Intrahepatic Cholangiocarcinoma.Emerging role of microRNAs in cancer stem cells: Implications in cancer therapyMicroRNA profiles involved in trifluridine resistance.Chemoresistance in pancreatic cancer: Emerging conceptsContinuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemotherapy.Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer.Pediatric brain tumor cells release exosomes with a miRNA repertoire that differs from exosomes secreted by normal cells.Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.Octamer 4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells.Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF.MicroRNA-1246 is an exosomal biomarker for aggressive prostate cancer.The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma.Redox-Sensitive Transcription Factor NRF2 Enhances Trophoblast Differentiation via Induction of miR-1246 and Aromatase.CCNG2 Overexpression Mediated by AKT Inhibits Tumor Cell Proliferation in Human Astrocytoma Cells.Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.The mitochondrial one-carbon metabolic pathway is associated with patient survival in pancreatic cancermiR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas
P2860
Q26744298-9F57201D-53BB-4094-8F2D-205D06F29D60Q26752473-0778D0BD-D82E-4520-843C-01F891F8668FQ26796523-BB1344A8-707F-4AA9-8F9F-37ECA6291D2FQ35191580-9D2F3D63-DD04-4375-B424-DE05EB0EC165Q35211914-0F9A2808-AE44-4F95-8048-44BC0CF5AD56Q36335693-FC84885D-8F9C-4C50-BCF5-EA339A6B1AB9Q36385805-6A923165-CE0F-4427-8029-B36A4358C1A7Q37508344-7928C716-95D9-4401-9583-ADAEDF9A463BQ37619633-ADCCFE6B-7545-4114-A4F6-3E75E3F5338CQ37642511-3DC8311E-24DE-4C5E-91E5-B04D03B74616Q37735617-D6AB4D99-C263-46AE-BB82-FFB796BE469AQ38546133-A46C4771-880C-41AA-B233-B975606D1EFAQ38748123-3FE5E14F-3D73-494C-BD2B-C0E56F7086AAQ38768272-D20B57F0-DF11-42A3-89D5-3799238C7D21Q39143971-061E414E-7B18-42D5-8424-85DC9FBA103FQ40509393-830C6DF6-D46E-424F-B15E-B733EAE740FDQ40676002-C854EA7F-64A5-43DF-BA83-C32B2C1BD71FQ41457379-EF903430-9765-4381-9FC0-1C62E5AFC0C2Q41593018-A677BC21-2783-42A6-AE76-A39E937E3A40Q42002078-4BF402C4-54A4-472D-A7DC-1B272C164CEAQ42041224-5B8795ED-38D7-4702-BF57-278C20D13EADQ43155431-8968D9A5-A470-45AD-8174-9307A39B7CD0Q46496918-2A256B98-4F1E-46F7-B7FC-7B3AD5178C0CQ47094133-0733D379-9C35-44C2-B6E3-E610C65C9DEBQ47107545-D8CDB41B-72AF-4D3D-A345-4DADD898A599Q48273193-52907172-EF8A-4CAC-A29C-3B4DAE014C12Q50019429-18D07324-BB28-4CF5-8E3A-13EA5D1FB2A0Q50046172-064EE782-EA35-4D3C-AD14-01AA1E4C3307Q50129161-69E1B7C4-8353-4540-8313-31B0818A776BQ51417097-69134A07-C393-4600-941A-ABEA4E64AD95Q54979866-846E7F5A-08F6-49D9-A834-50F4630D5A3AQ55403266-49A6E0F8-AAD4-49DD-B2D6-BD54FA47A09DQ57173332-E8481254-5D35-4372-80B6-24674E40CD9FQ58773180-BF1D405B-C2B2-46A6-82E5-25C7FD1F3125
P2860
MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MicroRNA-1246 expression assoc ...... stemness in pancreatic cancer
@ast
MicroRNA-1246 expression assoc ...... stemness in pancreatic cancer
@en
MicroRNA-1246 expression assoc ...... stemness in pancreatic cancer
@nl
type
label
MicroRNA-1246 expression assoc ...... stemness in pancreatic cancer
@ast
MicroRNA-1246 expression assoc ...... stemness in pancreatic cancer
@en
MicroRNA-1246 expression assoc ...... stemness in pancreatic cancer
@nl
prefLabel
MicroRNA-1246 expression assoc ...... stemness in pancreatic cancer
@ast
MicroRNA-1246 expression assoc ...... stemness in pancreatic cancer
@en
MicroRNA-1246 expression assoc ...... stemness in pancreatic cancer
@nl
P2093
P2860
P356
P1476
MicroRNA-1246 expression assoc ...... stemness in pancreatic cancer
@en
P2093
K Kawamoto
P2860
P2888
P304
P356
10.1038/BJC.2014.454
P407
P577
2014-08-12T00:00:00Z
P5875
P6179
1037787068